Pilot study for immunoglobulin E as a prognostic biomarker in coronavirus disease 2019.
Ozge Aydin GucluSeda S GoktasAsli Gorek DilektasliNilüfer Aylin Acet ÖztürkEzgi DemirdogenFunda CoskunDane EdigerAhmet UrsavasEsra UzaslanHasim A ErolNurdan D KaracayUmut Kaya SelMehmet KaradagPublished in: Internal medicine journal (2022)
Our single-centre pilot study determined that total IgE levels may be a negative prognostic factor for clinical progression in patients hospitalised due to COVID-19 infection. Future studies are required to determine the impact of individuals' underlying immune predispositions on outcomes of COVID-19 infections.